Novogenia

Novogenia

Novogenia was founded in 2009 by molecular biologist and epigeneticist Dr. Daniel Wallerstorfer near Salzburg, Austria. Wallerstorfer also wrote the book "Die Macht unserer Gene" ("The Power of our Genes"). Matthias Probst, a founder as well, serves as CFO and also oversees finances for other Darwin Group entities. The firm develops and markets genetic test kits designed for health and nutrition professionals — including ShapePlus for weight management, LifestylePlus for general wellness, and PerformancePlus for athletic performance. Tests are B2B only; practitioners purchase them to offer clients personalized supplement and cosmetic recommendations. Novogenia does not sell directly to consumers. Its science claims are based on gene variants supported by at least three independent studies (per the firm's website). Novogenia employs roughly 250 people in its 4,000 m² facility and is a subsidiary of Darwin AG, a publicly traded biotechnology holding listed on the Munich Stock Exchange since 2019 (per the firm's website). Darwin AG provides group-level synergies for R&D and operations. The firm lists no additional offices beyond its single Eugendorf site. Novogenia's structure is unusual for a lab: it operates as a subsidiary of a publicly listed biotech group rather than as a standalone private firm, which gives it access to capital markets while retaining a founder-led operating culture. Its revenue model depends entirely on professional intermediaries — nutritionists, fitness trainers, and medical professionals — who resell its tests to end users.